Views & Analysis What doctors say about Obamacare after US election Daniel Ghinn has been listening to the social media conversations of HCPs.
News Momentous 21st Century Cures is coming, but debate rages on The US Congress may pass the 21 Century Cures Act this week, a major new piece of legislation affecting healthcare, the FDA and pharma - but the battle for what measures will be included an
Views & Analysis AZ’s Soriot: Obamacare repeal likely, but globalisation can’... Soriot among first pharma leaders to comment on Trump victory
News 23andMe fined £2.31m over UK users' genetic data breach Genetic testing company 23andMe is facing a hefty fine from the UK's data protection watchdog for failing to protect its customers' data.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
